Richardson Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Richardson Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$159K	Buy	305 +95	+45%	+$48.6K	0.09%	191
2026 Q2	$104K	Sell	210 -667	-76%	-$296K	0.06%	230
2026 Q1	$392K	Sell	877 -75	-8%	-$35K	0.25%	100
2025 Q4	$432K	Buy	952 +10	+1%	+$4.31K	0.14%	90
2025 Q3	$369K	Sell	942 -78	-8%	-$32.6K	0.23%	101
2025 Q2	$461K	Buy	1,020 +6	+0.6%	+$2.76K	0.31%	93
2025 Q1	$492K	Buy	1,014 +40	+4%	+$18.6K	0.37%	82
2024 Q4	$389K	Buy	974 +8	+0.8%	+$3.71K	0.27%	97
2024 Q3	$453K	Buy	966 +4	+0.4%	+$1.92K	0.29%	87
2024 Q2	$451K	Buy	962 +25	+3%	+$10.9K	0.32%	82
2024 Q1	$392K	Buy	937 +340	+57%	+$144K	0.28%	96
2023 Q4	$243K	Buy	+597	New	+$221K	0.21%	109

Other funds holding VRTX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Richardson Financial Services's VRTX Position: Q3 2026 in Review

Richardson Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 45% in Q3 2026, buying an estimated $48.6K and bringing the position to 305 shares worth $159K. The position accounts for 0.09% of the portfolio, ranked #191.

Richardson Financial Services first reported a position in VRTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $492K in Q1 2025. 992 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Richardson Financial Services held 305 shares of Vertex Pharmaceuticals worth $159K as of Q3 2026.
Richardson Financial Services bought 95 Vertex Pharmaceuticals shares in Q3 2026, an estimated $48.6K.
Vertex Pharmaceuticals made up 0.09% of Richardson Financial Services's portfolio in Q3 2026, its #191 holding.
Richardson Financial Services first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
Richardson Financial Services's Vertex Pharmaceuticals position peaked at $492K in Q1 2025.
992 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Richardson Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.